These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21762609)

  • 41. Pulmonary toxoplasmosis after allogeneic bone marrow transplantation: case report and review.
    Saad R; Vincent JF; Cimon B; de Gentile L; Francois S; Bouachour G; Ifrah N
    Bone Marrow Transplant; 1996 Jul; 18(1):211-2. PubMed ID: 8832018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Great efficacy of sulfachloropyrazine-sodium against acute murine toxoplasmosis.
    Zeng YB; Zhu SH; Dong H; Han HY; Jiang LL; Wang Q; Cheng J; Zhao QP; Ma WJ; Huang B
    Asian Pac J Trop Biomed; 2012 Jan; 2(1):70-5. PubMed ID: 23569838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
    Araujo FG; Suzuki Y; Remington JS
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
    Faucher B; Moreau J; Zaegel O; Franck J; Piarroux R
    J Antimicrob Chemother; 2011 Jul; 66(7):1654-6. PubMed ID: 21459896
    [No Abstract]   [Full Text] [Related]  

  • 47. MRI of ocular toxoplasmosis.
    Low SC; Chan LL
    Neurology; 2006 Jun; 66(11):1660. PubMed ID: 16769936
    [No Abstract]   [Full Text] [Related]  

  • 48. [Toxoplasmosis in sick persons].
    Netrebko ID
    Lik Sprava; 2002; (8):90-3. PubMed ID: 12669554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiology, clinical aspects and therapy of toxoplasmosis].
    Alexander M
    Med Klin; 1970 Feb; 65(7):283-8. PubMed ID: 5534813
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
    Kieffer F; Thulliez P; Brézin A; Nobre R; Romand S; Yi-Gallimard E; Voyer M; Magny JF
    Arch Pediatr; 2002 Jan; 9(1):7-13. PubMed ID: 11865553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cerebral toxoplasmosis complicating an allograft with hematopoietic stem cells from peripheral blood].
    Dugauquier C; Bataille Y; Willems E; Frère P; De Prijck B; Beguin Y; Baron F
    Rev Med Liege; 2009; 64(7-8):366-9. PubMed ID: 19777912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.
    Beltrame A; Venturini S; Crichiutti G; Meroni V; Buonfrate D; Bassetti M
    Infection; 2016 Apr; 44(2):259-62. PubMed ID: 26168861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxoplasma seropositivity and depression: a case report.
    Kar N; Misra B
    BMC Psychiatry; 2004 Feb; 4():1. PubMed ID: 15018628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
    Wei HX; Wei SS; Lindsay DS; Peng HJ
    PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Development of a real-time PCR assay for quantitative diagnosis of Toxoplasma gondii after allogeneic bone marrow transplantation].
    Daval S; Poirier P; Armenaud J; Cambon M; Livrelli V
    Pathol Biol (Paris); 2010 Feb; 58(1):104-9. PubMed ID: 19892493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia].
    Olmos Soto S; Reus Bañuls S; Mora Castera E; Villarubia Lor MB
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):549-50. PubMed ID: 24913993
    [No Abstract]   [Full Text] [Related]  

  • 59. PCR detection of Toxoplasma gondii in human fetal tissues.
    Tóth T; Sziller I; Papp Z
    Methods Mol Biol; 1998; 92():195-202. PubMed ID: 9664515
    [No Abstract]   [Full Text] [Related]  

  • 60. Disseminated toxoplasmosis in an immunocompetent patient from Peruvian Amazon.
    Nunura J; Vásquez T; Endo S; Salazar D; Rodriguez A; Pereyra S; Solis H
    Rev Inst Med Trop Sao Paulo; 2010; 52(2):107-10. PubMed ID: 20464132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.